To address this limitation, we performed redirected T cell cytotoxicity assays using CBMC as a source of neonatal CD8+ T cells for use as effectors, and autologous cord blood CD4+ T cells for use as targets after infection with HIV-1 in vitro. The gene discussed is CD4; the disease is infection.